Their software integrates diverse data points from clinical and drug development fields to predict patient responses to therapies, allowing pharmaceutical and biotech companies to optimize trial design and increase success rates. The last investment of $2.00M in Series A was secured on 08 January 2024 from Accenture Ventures. This backing from a established firm like Accenture Ventures is a strong validation of the potential of QuantHealth's technology in transforming the pharmaceutical and AI industries.
QuantHealth
Accelerating drug development with AI-driven patient-centric medication simulations to enhance trial design and boost success rates.
Founded 2020
11-50 employees
Series A
Total: $17.00M
AI, Pharmaceutical
General Information
Get notified when QuantHealth moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track QuantHealth
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
About QuantHealth
Taxonomy: Drug Simulation, Bioinformatics, RWD/RWE, Computational Biology, Trial Simulation, Patient Centric Drug Development, In-Silico Medicine, Clinical Data Science, Health Informatics, Oncology, Auto-Immune, Respiratory, HemOnc, Drug R&D, Patient Outcomes
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 1 | •••• •••• | 08 Jan 2024 |
| Series A | •••••• | 7 |
|
30 Aug 2023 |
| Seed Round | •••••• | 1 |
|
10 Jun 2022 |
QuantHealth Alternatives & Competitors
QuantHealth vs
nference
United States
Making biomedical knowledge computable
Non Equity Assistance
313 employees
Biotechnology, Health Care
QuantHealth vs
EMINENT Services Corporation
United States
The Pre-EMINENT provider of Pharmaceutical, Biological and Info-Tech services.
23 employees
Biotechnology, Information Technology
QuantHealth vs
Pioneering genetically targeted therapies to swiftly translate breakthrough science into life-changi...
Series B
Biopharma, Biotechnology
FAQ About QuantHealth
Accelerating drug development with AI-driven patient-centric medication simulations to enhance trial design and boost success rates.
QuantHealth was founded in 2020.
QuantHealth operates in the following industries: AI, Pharmaceutical.
QuantHealth has approximately 11-50 employees.
QuantHealth has completed 3 funding rounds, raising a total of $17.00M. The latest funding stage is Series A.
Top alternatives and competitors to QuantHealth include nference, EMINENT Services Corporation, Eidos Therapeutics, IMIDomics Inc., BlackThorn Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
QuantHealth and nference are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors QuantHealth and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.